Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

Three Pharma Giants Bankroll Newcomer
To Develop PGx Tools for Drug Discovery

[July 23, 2008]

By Turna Ray

Boston-based Enlight Biosciences, backed with $39 million from Merck, Eli Lilly, and Pfizer, was founded to exploit mutually beneficial needs between academia and industry: Academic institutions’ funding need to commercialize their discoveries in healthcare technologies, and biopharmaceutical companies’ need for technologies that could boost the success rate of products in drug development.

Login | Subscribe